1. Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352.
2. Bousquet J, Schünemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy ClinImmunol [Internet]. 2020 Jan 1 [cited 2021 Dec 08];145(1):70–80.e3. Available from: https://pubmed.ncbi.nlm.nih.gov/31627910/. Accessed 27 Oct 2022
3. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhin. 2020;58(Suppl S29):1–464.
4. Klimek L, Berger W, Bousquet J, PK K, Smith P, Sole D, et al. MP-AzeFlu in moderate-to-severe allergic rhinitis: a literature review. Int Arch Allergy Immunol [Internet]. 2021 Nov 1 [cited 2021 Dec 1];182(11):1026–35. Available from: https://pubmed.ncbi.nlm.nih.gov/34082425/. Accessed 27 Oct 2022
5. Roca-Ferrer J, Pujols L, Pérez-González M, Alobid I, Callejas B, Vicens-Artés S, et al. Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers. Allergy Asthma Clin Immunol [Internet]. 2018 Dec 18 [cited 2021 Dec 01];14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30574167/. Accessed 27 Oct 2022